Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis
NCT02195258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95
Last updated 2014-07-21
Summary
this study is designed to identify the genetic factors which can be implicated in the salbutamol responsiveness for asthmatic children in pediatric emergency department
Conditions
Sponsors & Collaborators
-
Hôpital Necker-Enfants Malades
lead OTHER
Principal Investigators
-
Hélène Chappuy, MDPhD · APHP
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-05-31
- Completion
- 2013-06-30
Countries
- France
Study Locations
More Related Trials
-
Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
NCT00395096 ·Status: COMPLETED
-
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
NCT01524198 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Albuterol HFA MDI in Pediatric Participants With Asthma
NCT00577655 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
NCT00112411 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
NCT06261957 ·Status: COMPLETED ·Phase: PHASE3
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Genetic Determinants of the Response to Salbutamol Among Asthma Patients
NCT00162396 ·Status: UNKNOWN ·Phase: NA
-
Wheeze and Intermittent Treatment
NCT01142505 ·Status: COMPLETED ·Phase: PHASE3
-
Towards Participatory Paediatric Asthma Action Plans
NCT04810169 ·Status: COMPLETED
-
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
NCT00809757 ·Status: COMPLETED ·Phase: PHASE3
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Intravenous Terbutaline in Severe Status Asthmaticus
NCT00750568 ·Status: UNKNOWN
-
A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
NCT01656811 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Stress, Environment, and Genetics in Urban Children With Asthma
NCT00269256 ·Status: COMPLETED
-
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
NCT02040766 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of E004 in Children With Asthma
NCT01460511 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
NCT00497523 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast for Early Life Wheezing
NCT00115297 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
NCT01196377 ·Status: COMPLETED ·Phase: NA
-
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362 ·Status: COMPLETED ·Phase: PHASE2
-
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
NCT00585039 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
NCT00073814 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Dexamethasone in Pediatric Asthma Exacerbations
NCT02192827 ·Status: COMPLETED ·Phase: PHASE3